Advertisement

Index by author

January 01, 2012; Volume 40,Issue 1

  1. Barber, Jane

    1. In Vitro Inhibition of the Bile Salt Export Pump Correlates with Risk of Cholestatic Drug-Induced Liver Injury in Humans
      Sarah Dawson, Simone Stahl, Nikki Paul, Jane Barber and J. Gerald Kenna
      Drug Metabolism and Disposition January 2012, 40 (1) 130-138; DOI: https://doi.org/10.1124/dmd.111.040758

  2. Baucom, Christie C.

    1. Species-Dependent and Receptor-Selective Action of Bilobalide on the Function of Constitutive Androstane Receptor and Pregnane X Receptor
      Aik Jiang Lau, Guixiang Yang, Ganesh Rajaraman, Christie C. Baucom and Thomas K. H. Chang
      Drug Metabolism and Disposition January 2012, 40 (1) 178-186; DOI: https://doi.org/10.1124/dmd.111.042879

  3. Beauchemin, Stéphanie

    1. Effects of Chronic Renal Failure on Brain Drug Transporters in Rats
      Judith Naud, Louis-Philippe Laurin, Josée Michaud, Stéphanie Beauchemin, Francois A. Leblond and Vincent Pichette
      Drug Metabolism and Disposition January 2012, 40 (1) 39-46; DOI: https://doi.org/10.1124/dmd.111.041145

  4. Bell, Jordan C.

    1. Regulation of Cytochrome P450 4F11 by Nuclear Transcription Factor-κB
      Jordan C. Bell and Henry W. Strobel
      Drug Metabolism and Disposition January 2012, 40 (1) 205-211; DOI: https://doi.org/10.1124/dmd.111.041178

  5. Black, John Logan

    1. Frequency of Undetected CYP2D6 Hybrid Genes in Clinical Samples: Impact on Phenotype Prediction
      John Logan Black, Denise L. Walker, Dennis J. O'Kane and Maria Harmandayan
      Drug Metabolism and Disposition January 2012, 40 (1) 111-119; DOI: https://doi.org/10.1124/dmd.111.040832

  6. Bligh, S. W. Annie

    1. Debrisoquine Metabolism and CYP2D Expression in Marmoset Liver Microsomes
      Brian R. Cooke, S. W. Annie Bligh, Z. Richard Cybulski, Costas Ioannides and Michael Hall
      Drug Metabolism and Disposition January 2012, 40 (1) 70-75; DOI: https://doi.org/10.1124/dmd.111.041566

  7. Borts, David J.

    1. Human Metabolism of Lapatinib, a Dual Kinase Inhibitor: Implications for Hepatotoxicity
      Stephen Castellino, Michael O'Mara, Kevin Koch, David J. Borts, Gary D. Bowers and Christopher MacLauchlin
      Drug Metabolism and Disposition January 2012, 40 (1) 139-150; DOI: https://doi.org/10.1124/dmd.111.040949

  8. Boulenc, Xavier

    1. Effects of Omeprazole and Genetic Polymorphism of CYP2C19 on the Clopidogrel Active Metabolite
      Xavier Boulenc, Nassim Djebli, Juan Shi, Laurent Perrin, William Brian, Robert Van Horn and Fabrice Hurbin
      Drug Metabolism and Disposition January 2012, 40 (1) 187-197; DOI: https://doi.org/10.1124/dmd.111.040394

  9. Bowers, Gary D.

    1. Human Metabolism of Lapatinib, a Dual Kinase Inhibitor: Implications for Hepatotoxicity
      Stephen Castellino, Michael O'Mara, Kevin Koch, David J. Borts, Gary D. Bowers and Christopher MacLauchlin
      Drug Metabolism and Disposition January 2012, 40 (1) 139-150; DOI: https://doi.org/10.1124/dmd.111.040949

  10. Brian, William

    1. Effects of Omeprazole and Genetic Polymorphism of CYP2C19 on the Clopidogrel Active Metabolite
      Xavier Boulenc, Nassim Djebli, Juan Shi, Laurent Perrin, William Brian, Robert Van Horn and Fabrice Hurbin
      Drug Metabolism and Disposition January 2012, 40 (1) 187-197; DOI: https://doi.org/10.1124/dmd.111.040394
« Previous (Pages : 1 2 3 4 5 6 ... 14) Next »
Back to top

In this issue

Advertisement